CIK 0001727196
- Non-accelerated filer
Scholar Rock Holding Corp
Sign in to watch- Ticker
- SRRK
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 823750435
- Phone
- +1 857-259-3860
- Business address
- 301 BINNEY STREET, 3RD FLOOR, CAMBRIDGE, MA, 02142
- Open-market buys, last 90 days
- $11,999,922
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$11,999,922. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-16 | Nashat Amir Director | Grant or award · Stock Option (right to buy) | +13,000 | 13,000 | ||
| 2020-06-16 | Vaishnaw Akshay Director | Grant or award · Stock Option (right to buy) | +13,000 | 13,000 | ||
| 2020-05-20 | Kingsley Stuart A Director | Grant or award · Stock Option (right to buy) | +20,316 | 20,316 | ||
| 2020-02-06 | BUCKLER ALAN J. Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2020-02-06 | Mahanthappa Nagesh K. President and CEO | Grant or award · Stock Option (Right to Buy) | +164,000 | 164,000 | ||
| 2020-02-06 | CHYUNG YUNG H. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2020-02-06 | Moore Erin SVP, Finance | Grant or award · Stock Option (Right to Buy) | +50,600 | 50,600 | ||
| 2019-12-17 | Moore Erin SVP, Finance | Grant or award · Stock Option (Right to Buy) | +9,400 | 9,400 | ||
| 2019-12-10 | SPRINGER TIMOTHY A 10% owner | Gift | −296,000 | 2,376,567 | ||
| 2019-09-18 | Hallal David Director | Gift | −2,000 | 290,595 | ||
| 2019-09-03 | SPRINGER TIMOTHY A Director | Other disposition | −1,237,028 | 0 | ||
| 2019-08-19 | SPRINGER TIMOTHY A 10% owner | Gift | −296,000 | 2,672,567 | ||
| 2019-05-21 | FLIER JEFFREY S. Director | Grant or award · Stock Option (Right to Buy) | +10,158 | 10,158 | ||
| 2019-05-21 | Myles Edward H Director | Grant or award · Stock Option (Right to Buy) | +5,079 | 5,079 | ||
| 2019-05-21 | Gilman Michael Director | Grant or award · Stock Option (Right to Buy) | +10,158 | 10,158 | ||
| 2019-05-21 | Burow Kristina Director | Grant or award · Stock Option (Right to Buy) | +10,158 | 10,158 | ||
| 2019-05-21 | Vaishnaw Akshay Director | Grant or award · Stock Option (Right to Buy) | +20,316 | 20,316 | ||
| 2019-05-21 | Hallal David Director | Grant or award · Stock Option (Right to Buy) | +10,158 | 10,158 | ||
| 2019-05-21 | Nashat Amir Director | Grant or award · Stock Option (Right to Buy) | +10,158 | 10,158 | ||
| 2019-01-31 | Mahanthappa Nagesh K. President and CEO | Grant or award · Stock Option (Right to Buy) | +130,000 | 130,000 |
Page 27 of 33 · 642 trades